Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
63
OPGN Quote, Financials, Valuation and Earnings
Last price:
$15.7000
Seasonality move
:
-13.59%
Day range:
$11.5700 - $16.0000
52-week range:
$0.0000 - $16.0000
Dividend yield:
0%
P/E ratio:
39.33x
P/S ratio:
17.66x
P/B ratio:
15.60x
Volume:
9.4K
Avg. volume:
8.8K
1-year change:
2367.45%
Market cap:
$158.4M
Revenue:
$5.2M
EPS (TTM):
$0.40
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
-- | -- | -- | -- | -- |
|
ADGM
Adagio Medical Holdings, Inc.
|
-- | -$0.24 | -100% | -91.79% | $4.00 |
|
INBS
Intelligent Bio Solutions, Inc.
|
$1.4M | -- | 160.36% | -- | -- |
|
LAB
Standard BioTools, Inc.
|
$18M | -$0.02 | -60.4% | -72.53% | $1.65 |
|
LNSR
LENSAR, Inc.
|
$17.8M | -$0.08 | 30.98% | -90.51% | $15.00 |
|
MOVE
Movano, Inc.
|
$3.4M | -$7.10 | 76.06% | -41.21% | $30.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
$15.7300 | -- | $158.4M | 39.33x | $0.00 | 0% | 17.66x |
|
ADGM
Adagio Medical Holdings, Inc.
|
$1.01 | $4.00 | $21.4M | 218.00x | $0.00 | 0% | 113.05x |
|
INBS
Intelligent Bio Solutions, Inc.
|
$4.30 | -- | $4.1M | -- | $0.00 | 0% | 8.55x |
|
LAB
Standard BioTools, Inc.
|
$1.28 | $1.65 | $492.2M | -- | $0.00 | 0% | 3.77x |
|
LNSR
LENSAR, Inc.
|
$11.85 | $15.00 | $141.5M | -- | $0.00 | 0% | 2.37x |
|
MOVE
Movano, Inc.
|
$7.97 | $30.00 | $6.7M | -- | $0.00 | 0% | 12.06x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
16.9% | -29,843.088 | 205167.16% | 5.70x |
|
ADGM
Adagio Medical Holdings, Inc.
|
106.35% | 2.155 | 73.62% | 0.48x |
|
INBS
Intelligent Bio Solutions, Inc.
|
35.02% | 2.804 | 21.48% | 0.47x |
|
LAB
Standard BioTools, Inc.
|
6.41% | 0.589 | 5.49% | 1.93x |
|
LNSR
LENSAR, Inc.
|
-31.16% | -1.208 | 1.79% | 0.65x |
|
MOVE
Movano, Inc.
|
212.35% | 2.628 | 67.05% | 0.29x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OPGN
OpGen, Inc.
|
-$48.1K | -$702.2K | 70.06% | 89.47% | -5625.96% | -$333.3K |
|
ADGM
Adagio Medical Holdings, Inc.
|
-$531K | -$5.7M | -193.23% | -340.49% | -- | -$3.5M |
|
INBS
Intelligent Bio Solutions, Inc.
|
$214.9K | -$2.9M | -213.68% | -255.54% | -263.64% | -$2.9M |
|
LAB
Standard BioTools, Inc.
|
$9.5M | -$23.5M | -22.34% | -24.44% | -120.02% | -$23.1M |
|
LNSR
LENSAR, Inc.
|
$5.8M | -$7.6M | -684.94% | -1013.45% | -52.95% | -$3.5M |
|
MOVE
Movano, Inc.
|
-$200K | -$2.6M | -337.24% | -410.28% | -3238.75% | -$1.6M |
OpGen, Inc. vs. Competitors
-
Which has Higher Returns OPGN or ADGM?
Adagio Medical Holdings, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of --. OpGen, Inc.'s return on equity of 89.47% beat Adagio Medical Holdings, Inc.'s return on equity of -340.49%.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M ADGMAdagio Medical Holdings, Inc.-- -$0.66 $20.7M -
What do Analysts Say About OPGN or ADGM?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 90.72%. On the other hand Adagio Medical Holdings, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 296.04%. Given that Adagio Medical Holdings, Inc. has higher upside potential than OpGen, Inc., analysts believe Adagio Medical Holdings, Inc. is more attractive than OpGen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 ADGMAdagio Medical Holdings, Inc.1 0 0 -
Is OPGN or ADGM More Risky?
OpGen, Inc. has a beta of -3,464.998, which suggesting that the stock is 346599.75% less volatile than S&P 500. In comparison Adagio Medical Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock OPGN or ADGM?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Adagio Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. Adagio Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or ADGM?
OpGen, Inc. quarterly revenues are --, which are smaller than Adagio Medical Holdings, Inc. quarterly revenues of --. OpGen, Inc.'s net income of -$608.7K is higher than Adagio Medical Holdings, Inc.'s net income of -$10.1M. Notably, OpGen, Inc.'s price-to-earnings ratio is 39.33x while Adagio Medical Holdings, Inc.'s PE ratio is 218.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 17.66x versus 113.05x for Adagio Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.17.66x 39.33x -- -$608.7K ADGMAdagio Medical Holdings, Inc.113.05x 218.00x -- -$10.1M
-
Which has Higher Returns OPGN or INBS?
Intelligent Bio Solutions, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of -269.38%. OpGen, Inc.'s return on equity of 89.47% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M INBSIntelligent Bio Solutions, Inc.19.33% -$0.35 $5.4M -
What do Analysts Say About OPGN or INBS?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 90.72%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 2690.7%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than OpGen, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than OpGen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 INBSIntelligent Bio Solutions, Inc.0 0 0 -
Is OPGN or INBS More Risky?
OpGen, Inc. has a beta of -3,464.998, which suggesting that the stock is 346599.75% less volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock OPGN or INBS?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or INBS?
OpGen, Inc. quarterly revenues are --, which are smaller than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. OpGen, Inc.'s net income of -$608.7K is higher than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, OpGen, Inc.'s price-to-earnings ratio is 39.33x while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 17.66x versus 8.55x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.17.66x 39.33x -- -$608.7K INBSIntelligent Bio Solutions, Inc.8.55x -- $1.1M -$3M
-
Which has Higher Returns OPGN or LAB?
Standard BioTools, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of -162.05%. OpGen, Inc.'s return on equity of 89.47% beat Standard BioTools, Inc.'s return on equity of -24.44%.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M LABStandard BioTools, Inc.48.51% -$0.09 $427M -
What do Analysts Say About OPGN or LAB?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 90.72%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 21.09%. Given that OpGen, Inc. has higher upside potential than Standard BioTools, Inc., analysts believe OpGen, Inc. is more attractive than Standard BioTools, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 LABStandard BioTools, Inc.1 2 0 -
Is OPGN or LAB More Risky?
OpGen, Inc. has a beta of -3,464.998, which suggesting that the stock is 346599.75% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.
-
Which is a Better Dividend Stock OPGN or LAB?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or LAB?
OpGen, Inc. quarterly revenues are --, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. OpGen, Inc.'s net income of -$608.7K is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, OpGen, Inc.'s price-to-earnings ratio is 39.33x while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 17.66x versus 3.77x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.17.66x 39.33x -- -$608.7K LABStandard BioTools, Inc.3.77x -- $19.6M -$31.7M
-
Which has Higher Returns OPGN or LNSR?
LENSAR, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of -25.94%. OpGen, Inc.'s return on equity of 89.47% beat LENSAR, Inc.'s return on equity of -1013.45%.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M LNSRLENSAR, Inc.40.56% -$0.31 -$9.2M -
What do Analysts Say About OPGN or LNSR?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 90.72%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 26.58%. Given that OpGen, Inc. has higher upside potential than LENSAR, Inc., analysts believe OpGen, Inc. is more attractive than LENSAR, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 LNSRLENSAR, Inc.0 2 0 -
Is OPGN or LNSR More Risky?
OpGen, Inc. has a beta of -3,464.998, which suggesting that the stock is 346599.75% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.
-
Which is a Better Dividend Stock OPGN or LNSR?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or LNSR?
OpGen, Inc. quarterly revenues are --, which are smaller than LENSAR, Inc. quarterly revenues of $14.3M. OpGen, Inc.'s net income of -$608.7K is higher than LENSAR, Inc.'s net income of -$3.7M. Notably, OpGen, Inc.'s price-to-earnings ratio is 39.33x while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 17.66x versus 2.37x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.17.66x 39.33x -- -$608.7K LNSRLENSAR, Inc.2.37x -- $14.3M -$3.7M
-
Which has Higher Returns OPGN or MOVE?
Movano, Inc. has a net margin of -5629.82% compared to OpGen, Inc.'s net margin of -5036.25%. OpGen, Inc.'s return on equity of 89.47% beat Movano, Inc.'s return on equity of -410.28%.
Company Gross Margin Earnings Per Share Invested Capital OPGNOpGen, Inc.55.51% -$0.06 $12.2M MOVEMovano, Inc.-250% -$4.73 $1.5M -
What do Analysts Say About OPGN or MOVE?
OpGen, Inc. has a consensus price target of --, signalling upside risk potential of 90.72%. On the other hand Movano, Inc. has an analysts' consensus of $30.00 which suggests that it could grow by 3664.12%. Given that Movano, Inc. has higher upside potential than OpGen, Inc., analysts believe Movano, Inc. is more attractive than OpGen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPGNOpGen, Inc.0 0 0 MOVEMovano, Inc.0 0 0 -
Is OPGN or MOVE More Risky?
OpGen, Inc. has a beta of -3,464.998, which suggesting that the stock is 346599.75% less volatile than S&P 500. In comparison Movano, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock OPGN or MOVE?
OpGen, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Movano, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OpGen, Inc. pays -- of its earnings as a dividend. Movano, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPGN or MOVE?
OpGen, Inc. quarterly revenues are --, which are smaller than Movano, Inc. quarterly revenues of $80K. OpGen, Inc.'s net income of -$608.7K is higher than Movano, Inc.'s net income of -$4M. Notably, OpGen, Inc.'s price-to-earnings ratio is 39.33x while Movano, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OpGen, Inc. is 17.66x versus 12.06x for Movano, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPGNOpGen, Inc.17.66x 39.33x -- -$608.7K MOVEMovano, Inc.12.06x -- $80K -$4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.
